{"cveId": "CVE-2022-45611", "cwe": ["CWE-522", "CWE-522"], "cvss": [{"baseScore": "9.8", "version": "3.1", "Attack Vector": "None", "Attack Complexity": "Low", "Privileges Required": "None", "User Interaction": "None", "Scope": "Unchaged", "Confidentiality Impact": "High", "Integrity Impact": "High", "Availability Impact": "High"}], "references": ["https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder", "https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf", "https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf"], "description": ["An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information."], "published": "2023-08-22T19:16:30.167", "state": "PUBLIC", "vendorName": ["n/a"], "productName": ["n/a"], "github": {"advisories": [], "commits": [], "pocAdvisorie": null, "repo": null, "info": {}}, "pocList": []}